Sarsenova, M.; Stepanjuk, A.; Saare, M.; Kasvandik, S.; Soplepmann, P.; Mikeltadze, I.; Götte, M.; Salumets, A.; Peters, M.
Carboxypeptidase Inhibitor LXN Expression in Endometrial Tissue Is Menstrual Cycle Phase-Dependent and Is Upregulated in Endometriotic Lesions. Genes 2024, 15, 1086.
https://doi.org/10.3390/genes15081086
AMA Style
Sarsenova M, Stepanjuk A, Saare M, Kasvandik S, Soplepmann P, Mikeltadze I, Götte M, Salumets A, Peters M.
Carboxypeptidase Inhibitor LXN Expression in Endometrial Tissue Is Menstrual Cycle Phase-Dependent and Is Upregulated in Endometriotic Lesions. Genes. 2024; 15(8):1086.
https://doi.org/10.3390/genes15081086
Chicago/Turabian Style
Sarsenova, Meruert, Artjom Stepanjuk, Merli Saare, Sergo Kasvandik, Pille Soplepmann, Iveta Mikeltadze, Martin Götte, Andres Salumets, and Maire Peters.
2024. "Carboxypeptidase Inhibitor LXN Expression in Endometrial Tissue Is Menstrual Cycle Phase-Dependent and Is Upregulated in Endometriotic Lesions" Genes 15, no. 8: 1086.
https://doi.org/10.3390/genes15081086
APA Style
Sarsenova, M., Stepanjuk, A., Saare, M., Kasvandik, S., Soplepmann, P., Mikeltadze, I., Götte, M., Salumets, A., & Peters, M.
(2024). Carboxypeptidase Inhibitor LXN Expression in Endometrial Tissue Is Menstrual Cycle Phase-Dependent and Is Upregulated in Endometriotic Lesions. Genes, 15(8), 1086.
https://doi.org/10.3390/genes15081086
